BlackRock Health Sciences Trust (BME) Ownership
BME ownership summary
as of October 17, 2026- Institutions
- 20.1% of shares outstanding
- Insiders
- 0.00% of shares outstanding
- Shares outstanding
- 12.9M
- Float
- 0 shares available to trade
- Short interest
- 0.20% 26K shares short
- Days to cover
- 0.69 short interest down 39.2% vs prior month
- Institutions 20.05%
- Other investors 79.95%
BME insider transactions
latest 20| Date | Name | Transaction | Price | Shares | Value |
|---|---|---|---|---|---|
| 2019-06-28 | Cynthia Egan | Buy | $38.92 | 3,737 | $145,444 |
| 2017-08-15 | Gary Gordon Cope | Sell | $0.57 | 700,000 | $399,000 |
| 2017-07-24 | Alexander Tsakumis | Buy | $0.66 | 14,500 | $9,570 |
| 2017-07-21 | Alexander Tsakumis | Buy | $0.66 | 10,000 | $6,600 |
| 2017-06-06 | Gary Gordon Cope | Buy | $0.64 | 8,500 | $5,440 |
| 2017-06-05 | Gary Gordon Cope | Buy | $0.66 | 11,500 | $7,590 |
| 2017-05-15 | Gary Gordon Cope | Buy | $0.90 | 9,000 | $8,100 |
| 2017-05-02 | Gary Gordon Cope | Buy | $0.98 | 2,000 | $1,960 |
| 2017-02-09 | Gary Gordon Cope | Buy | $1.40 | 400 | $560 |
| 2017-02-02 | Gary Gordon Cope | Sell | $1.45 | 200,000 | $290,000 |
| 2016-11-07 | Gary Gordon Cope | Buy | $0.90 | 10,000 | $9,000 |
| 2016-03-28 | Gary Gordon Cope | Buy | $0.17 | 24,500 | $4,165 |
| 2016-03-25 | Gary Gordon Cope | Buy | $0.17 | 1,000 | $170 |
| 2016-03-24 | Gary Gordon Cope | Buy | $0.17 | 1,000 | $170 |
| 2016-03-23 | Gary Gordon Cope | Buy | $0.17 | 80,500 | $13,685 |
| 2016-03-22 | Gary Gordon Cope | Buy | $0.17 | 24,000 | $4,080 |
| 2016-01-27 | Gary Gordon Cope | Buy | $0.08 | 3,000 | $240 |
| 2016-01-26 | Gary Gordon Cope | Buy | $0.09 | 44,000 | $3,960 |
| 2016-01-25 | Gary Gordon Cope | Buy | $0.09 | 6,000 | $540 |
| 2016-01-14 | Gary Gordon Cope | Buy | $0.10 | 54,500 | $5,450 |
Reported trades by company officers, directors and other filers (including disclosures by members of Congress where EODHD lists them). "—" where the filing gives no share count.
BME shares outstanding
Year-end shares outstanding, adjusted for splits.
Who owns BME
Institutional investors own 20.1% of BlackRock Health Sciences's shares and insiders 0.00%. Short interest is 0.20% of the float, or 0.69 days of average trading volume. The share count rose 65.6% since 2014.
Related: BME key metrics, BME dividend history. See the BME stock overview for the latest quote and news.
BME ownership FAQ
What percentage of BlackRock Health Sciences is owned by institutions?
Institutions hold 20.1% of BlackRock Health Sciences's shares outstanding; insiders hold 0.00%.
What is BlackRock Health Sciences's short interest?
26K shares of BlackRock Health Sciences were sold short, 0.20% of the float; at the average daily volume it would take 0.69 days to cover.
Are insiders buying or selling BlackRock Health Sciences?
Of the latest 20 reported insider transactions in BlackRock Health Sciences (since January 14, 2016), 18 were purchases and 2 were sales.
How many shares of BlackRock Health Sciences are outstanding?
BlackRock Health Sciences has 12.9M shares outstanding, of which an unreported number are in the public float.